2 proven medicines in 1 pen
Xultophy® 100/3.6 is a once-daily combination medicine to be used along with diet and exercise to lower blood sugar in adults with type 2 diabetes uncontrolled on less than 50 units of long-acting insulin daily.
Xultophy® 100/3.6 combines 2 proven diabetes medicines—Tresiba® (insulin degludec) and Victoza® (liraglutide)—in 1 pen. That’s what makes it different. A single daily dose of Xultophy® 100/3.6 showed similar A1C results to 1 long-acting and up to 4 mealtime insulin injections.
Xultophy® 100/3.6 helps control blood sugar in 2 ways
It adds insulin when your body isn’t making enough to lower blood sugar throughout the day
It helps your pancreas work to produce more insulin when your blood sugar levels are high
What blood sugar control can do for you
In addition to diet and exercise, controlling your blood sugar before and after meals may help you achieve your A1C goal. Xultophy® 100/3.6 can lower blood sugar for a full 24 hours, including after you eat, so you can stay in control all day long. And controlling your blood sugar is an important part of achieving your A1C goal.
Low blood sugar is a common side effect of insulin and insulin-containing products like Xultophy® 100/3.6. In studies, up to 1.2% of people taking Xultophy® 100/3.6 reported episodes of very low blood sugar.
Get a personalized diabetes support plan at no cost to you
Whether you're taking Xultophy® 100/3.6 or not, you have access to a free diabetes support program from Novo Nordisk. Create your own support plan based on your individual needs to manage diabetes your way.
Diabetes Health Coach
If you are taking Xultophy® 100/3.6, you have access to one-on-one phone calls with a Diabetes Health Coach—a Certified Diabetes Educator.
Learn from online coaching sessions and videos about how to manage your diabetes.
Receive regular reminders and ongoing encouragement via email.